Dyslipidemia and Risk of Cardiovascular Events in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Therapy: Insights From the ARISTOTLE (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation) Tria
about
Dyslipidemia and Risk of Cardiovascular Events in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Therapy: Insights From the ARISTOTLE (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation) Tria
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh
2018年學術文章
@zh-hant
name
Dyslipidemia and Risk of Cardi ...... s in Atrial Fibrillation) Tria
@en
Dyslipidemia and Risk of Cardi ...... y: Insights From the ARISTOTLE
@nl
type
label
Dyslipidemia and Risk of Cardi ...... s in Atrial Fibrillation) Tria
@en
Dyslipidemia and Risk of Cardi ...... y: Insights From the ARISTOTLE
@nl
prefLabel
Dyslipidemia and Risk of Cardi ...... s in Atrial Fibrillation) Tria
@en
Dyslipidemia and Risk of Cardi ...... y: Insights From the ARISTOTLE
@nl
P2093
P2860
P50
P921
P356
P1476
Dyslipidemia and Risk of Cardi ...... s in Atrial Fibrillation) Tria
@en
P2093
Johan Westerbergh
John H Alexander
Kurt Huber
Marco Alings
Michael Hanna
Renato D Lopes
Shinya Goto
Sigrun Halvorsen
Witold Ruzyllo
P2860
P356
10.1161/JAHA.117.007444
P577
2018-02-01T00:00:00Z